Depigmenting agents are compounds intended to reduce skin pigmentation, typically by inhibiting melanin synthesis (e.g., tyrosinase inhibition) or accelerating melanin turnover. They are used to address hyperpigmentation conditions such as melasma, post-inflammatory hyperpigmentation, and lentigines.
| Reported effect | How often | Notes |
|---|---|---|
| Skin irritation (erythema, stinging, dryness) | Common | Often dose- and concentration-dependent; usually mild and transient. |
| Contact dermatitis | Uncommon | May be irritant or allergic in nature depending on the specific agent. |
| Increased photosensitivity | Uncommon | Lightened skin may be more vulnerable to UV damage; sun protection is advised. |
| Paradoxical hyperpigmentation or uneven lightening | Rare | Can occur with overuse or irritation-induced post-inflammatory changes. |
| Exogenous ochronosis | Rare | Bluish-black discoloration reported with prolonged use of certain agents such as high-concentration hydroquinone. |
Frequencies reflect typical cosmetic use reported in the literature, not a guarantee for your skin.